| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $245.3M | -6.5% |
| Cost of Revenue | $178.4M | -4.3% |
| Gross Profit | $66.9M | -11.9% |
| R&D Expense | $59.2M | +12.5% |
| SG&A Expense | $27.3M | -3.2% |
| Operating Income | -$57.9M | -24.5% |
| Pre-tax Income | -$68.4M | -43.4% |
| Income Tax | -$465K | -343.5% |
| Net Income | -$68.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -84.6% |
| Accounts Receivable | $25.3M | -5.7% |
| Inventory | $38.0M | +1.5% |
| Current Assets | $78.4M | -38.6% |
| Total Assets | $159.0M | -26.3% |
| Current Liabilities | $57.0M | -23.9% |
| Total Liabilities | $229.1M | -4.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.3M | -32.0% |
| Capital Expenditures | $1.5M | -69.9% |
| Investing Cash Flow | -$13.3M | -319.1% |
| Financing Cash Flow | $5.4M | -81.9% |
| Free Cash Flow | -$34.8M | -15.4% |
| -41.2% |
| EPS (Basic) | -$0.66 | -29.4% |
| EPS (Diluted) | -$0.66 | -29.4% |
| Stockholders' Equity |
| -$70.1M |
| -182.1% |